Omniscient is delivering practical and intuitive software solutions to connect pioneers in neurosurgery, neurology, and neuroscience with subject-specific brain analytics.Omniscient has built intuitive and practical software solutions - specific to the needs of neurosurgeons, neurologists, psychiatrists, clinical researchers, and academics - which can be easily integrated with existing diagnostic, therapeutic, and surgical workflows. Their browser-based platform turns MRI scans available at most sites into comprehensive brain maps - all within an hour.
By combining three distinct pillars of expertise, their purpose-built, enterprise-grade platforms deliver an intuitive and integrated solution to map the human brain. At Omniscient, their founders Dr. Michael Sughrue and Dr. Stephane Doyen, joined by Stephen Scheeler, lead teams of diverse and passionate individuals that all believe brains can get better. Their mission is to radically change the care of patients with brain disease by harnessing machine learning/AI, big data, and connectomics to make personalized, precision neuroscience a reality.
Total Funding: A$60,000,000
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2B
Company Size: 51 to 100
Founded: 2019